Ctsz Gene Cathepsin Z is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| CTSZ Gene |
|---|
| Gene Symbol | CTSZ |
| Full Name | Cathepsin Z |
| Chromosomal Location | 20q13.12 |
| NCBI Gene ID | [1522](https://www.ncbi.nlm.nih.gov/gene/1522) |
| OMIM ID | 602088 |
| Ensembl ID | [ENSG00000021574](https://www.ensembl.org/Homo_sapiens/ENSG00000021574) |
| UniProt ID | [O60840](https://www.uniprot.org/uniprot/O60840) |
| Protein Name | Cathepsin Z (Cathepsin X) |
| Aliases | CTSX, CATZ, Cysteinyl Aminopeptidase |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Cancer, Lysosomal Storage Disorders |
CTSZ (Cathepsin Z), also known as Cathepsin X, is a unique lysosomal cysteine protease that possesses both endopeptidase and carboxypeptidase activities. Unlike other cathepsins, CTSZ contains an extended proline-rich region and a unique C-terminal tail that mediates its distinctive functions. It is widely expressed across tissues with particularly high levels in immune cells, brain, and various epithelial surfaces.
CTSZ exhibits unique catalytic properties:
- Dual Activity: Functions as both endopeptidase and carboxypeptidase
- pH Optimum: Active in acidic lysosomal environment (pH 4-6)
- Substrate Specificity: Prefers hydrophobic and basic residues at P1 position
- Lysosomal Protein Degradation: Central role in cellular protein turnover
- Immune Regulation: Modulates T-cell function and macrophage activity
- Extracellular Matrix Remodeling: Degrades ECM components
- Peptide Hormone Processing: Generates bioactive peptides from precursors
- Wound Healing: Promotes cell migration and tissue repair
CTSZ is expressed in:
- Immune cells (macrophages, neutrophils, T cells)
- Brain (neurons, microglia, astrocytes)
- Epithelial tissues (intestine, lung, prostate)
- Lysosomes of most cell types
CTSZ involvement in AD includes:
- Aβ Metabolism: May degrade amyloid-beta peptides
- Lysosomal Dysfunction: Altered CTSZ in AD brain lysosomes
- Tau Pathology: Interaction with tau processing
- Neuroinflammation: Microglial CTSZ regulates cytokine production
- Neuronal Loss: Increased CTSZ in vulnerable brain regions
In PD, CTSZ contributes to:
- α-Synuclein Turnover: Lysosomal degradation of α-synuclein aggregates
- Dopaminergic Neuron Vulnerability: Altered lysosomal function in SNc
- GBA Connection: Interaction with glucocerebrosidase pathway
- Autophagy Pathway: CTSZ deficiency impairs autophagic flux
- Huntington's Disease: Altered lysosomal cathepsin expression
- ALS: Dysregulated CTSZ in motor neuron disease
- Multiple System Atrophy: Lysosomal dysfunction includes CTSZ changes
CTSZ is a potential therapeutic target:
- Enzyme Inhibition: Selective CTSZ inhibitors may modulate neuroinflammation
- Enhancing Clearance: Activators could promote protein aggregate removal
- Immune Modulation: Targeting CTSZ in microglia
- No CTSZ-specific drugs in clinical trials for neurodegeneration
- Cathepsin inhibitors in development for cancer may be repurposed
- Gene therapy approaches to enhance lysosomal function
- Bernstein et al. (2007): CTSZ is overexpressed in AD brain and localizes to amyloid plaques
- Nagai et al. (2013): CTSZ deficiency leads to accumulation of autophagic vacuoles
- Zhang et al. (2018): CTSZ rs390344 polymorphism associated with PD risk
- CST3 (Cystatin C): Endogenous inhibitor
- GBA: Glucocerebrosidase pathway
- CtsB, CtsD, CtsL: Other cathepsins
- TGF-β: Growth factor processing
The study of Ctsz Gene Cathepsin Z has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.